5HVU

Rho-associated protein kinase 1 (ROCK 1) in complex with a pyridine thiazole piperidine inhibitor


Experimental Data Snapshot

  • Method: X-RAY DIFFRACTION
  • Resolution: 2.8 Å
  • R-Value Free: 0.248 
  • R-Value Work: 0.238 

wwPDB Validation 3D Report Full Report


This is version 1.2 of the entry. See complete history

Literature

ROCK inhibitors 2. Improving potency, selectivity and solubility through the application of rationally designed solubilizing groups.

Gao, H.Marhefka, C.Jacobs, M.D.Cao, J.Bandarage, U.K.Green, J.

(2018) Bioorg. Med. Chem. Lett. --: --

  • DOI: 10.1016/j.bmcl.2018.06.043
  • Also Cited By: 4YVE

  • PubMed Abstract: 
  • Solubilizing groups have been frequently appended to kinase inhibitor drug molecules when solubility is insufficient for pharmaceutical development. Such groups are usually located at substitution sites that have minimal impact on target activity. In ...

    Solubilizing groups have been frequently appended to kinase inhibitor drug molecules when solubility is insufficient for pharmaceutical development. Such groups are usually located at substitution sites that have minimal impact on target activity. In this report we describe the incorporation of solubilizing groups in a class of Rho kinase (ROCK) inhibitors that not only confer improved solubility, but also enhance target potency and selectivity against a closely related kinase, PKA.


    Organizational Affiliation

    Vertex Pharmaceuticals, Incorporated, 50 Northern Avenue, Boston, MA 02210, USA. Electronic address: jeremy_green@vrtx.com.,Vertex Pharmaceuticals, Incorporated, 50 Northern Avenue, Boston, MA 02210, USA.




Macromolecules

Find similar proteins by: Sequence  |  Structure

Entity ID: 1
MoleculeChainsSequence LengthOrganismDetails
Rho-associated protein kinase 1
A, B
415Homo sapiensMutation(s): 0 
Gene Names: ROCK1
EC: 2.7.11.1
Find proteins for Q13464 (Homo sapiens)
Go to Gene View: ROCK1
Go to UniProtKB:  Q13464
Small Molecules
Ligands 1 Unique
IDChainsName / Formula / InChI Key2D Diagram3D Interactions
65R
Query on 65R

Download SDF File 
Download CCD File 
A, B
2-{3-[3-(piperidin-4-yl)propoxy]phenyl}-N-[4-(pyridin-4-yl)-1,3-thiazol-2-yl]acetamide
C24 H28 N4 O2 S
IMDMAPNWXDTADU-UHFFFAOYSA-N
 Ligand Interaction
Experimental Data & Validation

Experimental Data

  • Method: X-RAY DIFFRACTION
  • Resolution: 2.8 Å
  • R-Value Free: 0.248 
  • R-Value Work: 0.238 
  • Space Group: P 31 2 1
Unit Cell:
Length (Å)Angle (°)
a = 181.820α = 90.00
b = 181.820β = 90.00
c = 90.600γ = 120.00
Software Package:
Software NamePurpose
PDB_EXTRACTdata extraction
BUSTER-TNTrefinement
d*TREKdata scaling
d*TREKdata reduction
BUSTERphasing

Structure Validation

View Full Validation Report or Ramachandran Plots



Entry History 

Deposition Data

  • Deposited Date: 2016-01-28 
  • Released Date: 2017-02-08 
  • Deposition Author(s): Jacobs, M.J.

Revision History 

  • Version 1.0: 2017-02-08
    Type: Initial release
  • Version 1.1: 2017-11-01
    Type: Author supporting evidence
  • Version 1.2: 2018-07-18
    Type: Data collection, Database references